Results 281 to 290 of about 199,665 (351)

Dyslipidemia Fact Sheet in South Korea, 2024. [PDF]

J Lipid Atheroscler
Kwon O, Lee SY, Kim B, Han K, Ahn J, Committee of Public Relations of the Korean Society of Lipid and Atherosclerosis.   +5 more
europepmc   +1 more source

Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression [PDF]

, 1993
Carroll, P, Fung, JJ, Jordan, M, McCauley, J, Odocha, O, Scantlebury, V, Shapiro, R, Starzl, TE, Vivas, C   +8 more
core  

A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of Posdinemab (JNJ‐63733657) in Healthy Chinese Adults

The Journal of Clinical Pharmacology, Volume 66, Issue 2, February 2026.
Abstract Posdinemab, a humanized immunoglobulin G1/κ monoclonal antibody, binds with high affinity to phosphorylated tau protein which is associated with Alzheimer's disease (AD) pathophysiology. Posdinemab reduced tau seeding in murine models and was well tolerated in Phase‐1 clinical studies.
Fangfang Wang, Juanfang Liu, Daisy Bai, Lingjue Li, Maggie Fedgchin, David Henley, Haiyan Li, Fan Zhang   +7 more
wiley   +1 more source

Vascular risk factors may increase the risk of developing Alzheimer's disease comorbid with cerebral small vessel disease. [PDF]

Chin Med J (Engl)
Li Q, Feng Y, Zhang N, Zhan J, Liao Z, Li X.   +5 more
europepmc   +1 more source

Rosuvastatin in Combination With Bortezomib Promotes Osteogenesis in Myeloma Bone Disease by Inhibiting the Secretion of CCL3

eJHaem, Volume 7, Issue 1, February 2026.
ABSTRACT Background Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM) and a primary cause of disability in affected patients. Its pathogenesis is driven by an imbalance in bone remodeling, largely attributed to the overexpression of C‐C motif chemokine ligand 3 (CCL3). While both bortezomib and statins have been reported
Fujun Qu, Mingxu Hui, Fan Yang, Bo Huang, Nian Liu, Yuchan He, Xiaotao Wang   +6 more
wiley   +1 more source

Hypoxic Training with Calorie Restriction Improves Lipid Profile and Body Composition in Men with Obesity-Related Hypercholesterolemia: A Controlled Intervention Study. [PDF]

Int J Mol Sci
Jędrzejewski E, Czuba M, Niemaszyk A, Płoszczyca K, Kaczmarczyk K, Langfort J, Gajda R.   +6 more
europepmc   +1 more source

Ablation of Ventricular Tachycardia Using the QDOT MICRO Ablation Catheter (VT‐MICRO Study)

Journal of Arrhythmia, Volume 42, Issue 1, February 2026.
Catheter ablation is useful to treat patients with ventricular tachycardia. QDOT Micro catheter is a next generation catheter designed to provide more efficient lesion creation with an accurate myocardial substrate analysis. Microelectrode mapping allows detection of higher voltage electrograms compared to standard bipolar mapping and Pentaray mapping.
Antonio Di Monaco, Davide Ciliberti, Alberto Martinelli, Federico Quadrini, Federica Troisi, Nicola Vitulano, Massimo Grimaldi   +6 more
wiley   +1 more source

<i>Usp21</i> Knockout Causes Abnormal Lipid Metabolism in Mouse and Its Polymorphism Correlates with Hypercholesterolemia in Outpatients. [PDF]

Int J Mol Sci
Iyer S, Hattori N, Okuda H, Nakagawa T, Fujii S, Maeda T, Koseki H, Ito T.   +7 more
europepmc   +1 more source

Bile Acid Binding Resins Improve Glucagon Receptor Agonist‐Mediated Weight Loss in Diet‐Induced Obese Mice

Obesity, Volume 34, Issue 2, Page 428-438, February 2026.
ABSTRACT Objective Glucagon‐receptor (GCGR) agonism reguglates bile acid (BA) metabolism and promotes weight loss in diet‐induced obese (DIO) mice. Thus, we hypothesized that BA signaling contributes to GCGR‐stimulated weight loss. Methods To test this hypothesis, we utilized BA‐binding resins (BARs; colesevelam [Colsv] and cholestyramine [Cstyr]) to ...
Teayoun Kim, Mackenzie J. Pearson, Huixian Hong, Shelly Nason, Khadija Seck, Jessica Antipenko, Natalie Presedo, Richard DiMarchi, William C. Roell, Kirk Habegger   +9 more
wiley   +1 more source

Rethinking Statin Dosage in Coronary Disease

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
It is widely acknowledged that a sufficient statin dose is important in the management of symptomatic coronary disease, along with weight reduction and appropriate antithrombotic, blood pressure, and diabetes pharmacotherapy. Mid‐range statin doses have been shown to achieve the maximum improvements in total mortality and have the advantage of greater ...
Simon B. Dimmitt, Hans G. Stampfer, Michael C. Kennedy, Jennifer H. Martin   +3 more
wiley   +1 more source